Guidelines for treating movement problems in people in the early stages of Parkinson’s disease have been updated. The new treatment recommendations from the American Academy of Neurology (AAN) focus on dopaminergic medications, which increase dopamine levels or mimic dopamine effects. Parkinson’s is a movement disorder that occurs when nerve cells in the brain fail to…  read on >  read on >

Neurologists must make sure Alzheimer’s patients and their families understand that the controversial drug aducanumab does not restore mental function, the American Academy of Neurology (AAN) said in new position statement that includes ethical guidelines. “Aducanumab is not a cure for Alzheimer’s disease, yet since it has been approved by the [U.S. Food and Drug…  read on >  read on >

Race-based gaps in health care and health outcomes persist in every region of the United States, a new state-by-state report card shows. Racial and ethnic disparities woven throughout America and its system of health care mean that people of color are more likely to die younger from preventable illnesses than white people, according to a…  read on >  read on >

Despite stereotypes about seniors and technology, a small study suggests that older adults in the early stages of dementia can use smartphone apps as memory aids. The researchers found that older people with mild impairments in memory and thinking were not only able to learn how to use the apps, they said the digital aids…  read on >  read on >

Gene therapy shows promise in reducing, and even halting, potentially life-threatening bleeding events in people with hemophilia, researchers report. Hemophilia A is the most common inherited bleeding disorder, affecting one in 5,000 males worldwide. It’s caused by a missing coagulation factor called FVIII. The current standard of care involves regular infusions of the FVIII protein,…  read on >  read on >